About the Authors

Frédéric-Antoine Dauchy

frederic.dauchy@chu-bordeaux.fr

Affiliations University of Bordeaux, laboratoire de parasitologie, France, IRD-CIRAD-University of Bordeaux, France, University Hospital of Bordeaux, Department of infectious and tropical diseases, Hôpital Pellegrin, France

Mélanie Bonhivers

Affiliations University of Bordeaux, Microbiologie Fondamentale et Pathogénicité, France, CNRS, Microbiologie Fondamentale et Pathogénicité, France

Nicolas Landrein

Affiliations University of Bordeaux, Microbiologie Fondamentale et Pathogénicité, France, CNRS, Microbiologie Fondamentale et Pathogénicité, France

Denis Dacheux

Affiliations University of Bordeaux, Microbiologie Fondamentale et Pathogénicité, France, CNRS, Microbiologie Fondamentale et Pathogénicité, France, Bordeaux INP, ENSTBB, Microbiologie Fondamentale et Pathogénicité, France

Pierrette Courtois

Affiliations University of Bordeaux, laboratoire de parasitologie, France, IRD-CIRAD-University of Bordeaux, France

Florian Lauruol

Affiliations University of Bordeaux, laboratoire de parasitologie, France, IRD-CIRAD-University of Bordeaux, France

Sylvie Daulouède

Affiliations University of Bordeaux, laboratoire de parasitologie, France, IRD-CIRAD-University of Bordeaux, France

Philippe Vincendeau

Contributed equally to this work with: Philippe Vincendeau, Derrick R. Robinson

Affiliations University of Bordeaux, laboratoire de parasitologie, France, IRD-CIRAD-University of Bordeaux, France, University Hospital of Bordeaux, laboratoire de parasitologie, Hôpital Pellegrin, France

Derrick R. Robinson

Contributed equally to this work with: Philippe Vincendeau, Derrick R. Robinson

Affiliations University of Bordeaux, Microbiologie Fondamentale et Pathogénicité, France, CNRS, Microbiologie Fondamentale et Pathogénicité, France

Competing Interests

I have read the journal's policy and the authors of this manuscript have the following competing interests: We thank Dr. Péré Perez Simarro and Jose Ramon Franco (World Health Organization) for the supply of eflornithine (ornidyl, Sanofi aventis) and nifurtimox (lampit, Bayer). Merck Sharp & Dohme Corp and Bayer provided posaconazole and nifurtimox respectively, for in vitro experimentation. The companies (Sanofi aventis, Bayer, Merck Sharp & Dohme Corp) did not play any additional role in the study aside from providing supplies.

Author Contributions

Conceived and designed the experiments: FAD MB DD SD PV DRR. Performed the experiments: FAD MB DD PC NL FL. Analyzed the data: FAD MB PV DRR. Contributed reagents/materials/analysis tools: PV DRR. Wrote the paper: FAD MB PV DRR.